tag:blogger.com,1999:blog-4384692836709903146.post7390801739609393227..comments2024-03-27T09:55:23.143-07:00Comments on Dispatch from the Digital Health Frontier: Digital Signatures with SAFE-BioPharmaJohn Halamkahttp://www.blogger.com/profile/04550236129132159307noreply@blogger.comBlogger1125tag:blogger.com,1999:blog-4384692836709903146.post-15316066279471072952010-05-24T07:05:31.853-07:002010-05-24T07:05:31.853-07:00Nice job. SAFE-BioPharma has been involved in the ...Nice job. SAFE-BioPharma has been involved in the IHE efforts to define the Digital Signature Content Profile (DSG). What they bring to the table is an infrastructure for high-assurance non-repudiation of origin. This high-assurance non-repudiation is critical when the risks to falsification of content are high. The root cases for SAFE-BioPharma are clinical trials evidence in the Bio-Pharmacy industry. They have worked closely with the FDA to move from a purely paper submission, which was piles and piles of paper; to an electronic submission with digital signatures. A very 'green' effort that they also need to be recognized for.<br /><br />JohnJohn Moehrkehttps://www.blogger.com/profile/04526719420117446030noreply@blogger.com